Cleared Traditional

K230736 - MagnetOs Putty

K230736 is an FDA 510(k) clearance for MagnetOs Putty, manufactured by Kuros Biosciences B.V. The device is a Class 2 Orthopedic device with product code MQV cleared through the Traditional 510(k) pathway after a 278-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2023
Decision
278d
Days
Class 2
Risk

K230736 is an FDA 510(k) clearance for the MagnetOs Putty. Classified as Filler, Bone Void, Calcium Compound (product code MQV), Class II - Special Controls.

Submitted by Kuros Biosciences B.V (Bilthoven, NL). The FDA issued a Cleared decision on December 20, 2023 after a review of 278 days - an extended review cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3045 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Kuros Biosciences B.V devices

FDA 510(k) Submission Details - K230736

510(k) Number K230736 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 17, 2023
Decision Date December 20, 2023
Days to Decision 278 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
156d slower than avg
Panel avg: 122d · This submission: 278d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MQV Device Classification - Class 2, Special Controls

Product Code MQV Filler, Bone Void, Calcium Compound
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3045
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - MQV Filler, Bone Void, Calcium Compound

All 290
Devices cleared under the same product code (MQV) and FDA review panel - the closest regulatory comparables to K230736.
ReBOSSIS
K240453 · Orthorebirth Co., Ltd. · Mar 2024
Mg OSTEOINJECT™
K234013 · Bone Solutions, Inc. · Feb 2024
MagnetOs Granules
K232347 · Kuros Biosciences B.V · Jan 2024
Tactoset® Injectable Bone Substitute
K231968 · Anika Therapeutics, Inc. · Dec 2023
MagnetOs Easypack Putty
K233607 · Kuros Biosciences B.V · Dec 2023
SIGNAFUSE Bioactive Strip (SBS)
K233490 · Bioventus, LLC · Dec 2023